June 2018 - Restech

Home
Our solutions
- First
- Resmon Pro
- Resolve
Company
About Oscillometry
Contacts

A new paper on the use of RESMON PRO FULL to evaluate the effects of airway clearance on patients with cystic fibrosis is available online!

Prof Wallaert and its research group in Belgium used the RESMON PRO FULL to investigate the effects of autogenic drainage technique on ventilatory mechanics in adult with cystic fibrosis. According to the authors: "The FOT opens up new avenues of mechanistic...

Jun 12, 2018

First

Resmon Pro

Resolve

About Oscillometry

Company

via Melchiorre Gioia, 63/61
20124 Milan Italy
T: (+39) 02.36.59.36.90
F: (+39) 02.36.59.36.92

REA: MI-1936811| RESTECH P.IVA/CF: 07116980967
privacy policy

The first mini-oscillometer, a revolution in pulmonary diagnostics.

First is a novel, revolutionary unique medical device for easy, fast, reliable measurements of respiratory function at normal tidal breathing, all in a compact stand-alone handheld device. First utilizes the proven and validated method of OSCILLOMETRY or FOT (forced oscillatory technique) to detect and localize peripheral and central obstructions, as well as tidal Expiratory Flow Limitation (EFLt).

Discover more

SCIENTIFIC PAPERS

1. Walker PP, Pompilio PP, Zanaboni P, et al. Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial. Am J Respir Crit Care Med. 2018;198(5):620-628. doi:10.1164/rccm.201712-2404OC

2. Gobbi A, Milesi I, Govoni L, Pedotti A, Dellacà RL. A New Telemedicine System for the Home Monitoring of Lung Function in Patients with Obstructive Respiratory Diseases. 2009 Int Conf eHealth, Telemedicine, Soc Med. February 2009:117-122. doi:10.1109/eTELEMED.2009.18

3. Zimmermann SC, Huvanandana J, Nguyen CD, et al. Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD. Eur Respir J. 2020;56(3). doi:10.1183/13993003.01739-2019

4. Gobbi A, Gulotta C, Suki B, et al. Monitoring of respiratory resistance in the diagnosis of mild-intermittent asthma. Clin Exp Allergy. 2019:0-1. doi:10.1111/cea.13376

5. Gobbi A, Dellacá RL, King G, Thamrin C. Toward Predicting Individual Risk in Asthma Using Daily Home Monitoring of Resistance. Am J Respir Crit Care Med. 2017;195(2):265-267. doi:10.1164/rccm.201603-0537LE